Carteolol hydrochloride - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for carteolol hydrochloride and what is the scope of patent protection?

Carteolol hydrochloride is the generic ingredient in three branded drugs marketed by Apotex Inc, Bausch And Lomb, Sandoz, Novartis, and Abbvie, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for carteolol hydrochloride. One supplier is listed for this compound.

Summary for carteolol hydrochloride

US Patents:	0
Tradenames:	3
Applicants:	5
NDAs:	5
Drug Master File Entries:	3
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	70
Clinical Trials:	2
Patent Applications:	1,185
What excipients (inactive ingredients) are in carteolol hydrochloride?	carteolol hydrochloride excipients list
DailyMed Link:	carteolol hydrochloride at DailyMed

Recent Clinical Trials for carteolol hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Otsuka Pharmaceutical Co., Ltd.	Phase 1
Otsuka Pharmaceutical Co., Ltd.	Phase 3

See all carteolol hydrochloride clinical trials

Pharmacology for carteolol hydrochloride

Drug Class	beta-Adrenergic Blocker
Mechanism of Action	Adrenergic beta-Antagonists

Medical Subject Heading (MeSH) Categories for carteolol hydrochloride

Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Antihypertensive Agents
Sympatholytics

Anatomical Therapeutic Chemical (ATC) Classes for carteolol hydrochloride

C07AA	Beta blocking agents, non-selective
C07A	BETA BLOCKING AGENTS
C07	BETA BLOCKING AGENTS
C	Cardiovascular system

S01ED	Beta blocking agents
S01E	ANTIGLAUCOMA PREPARATIONS AND MIOTICS
S01	OPHTHALMOLOGICALS
S	Sensory organs

US Patents and Regulatory Information for carteolol hydrochloride

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abbvie	CARTROL	carteolol hydrochloride	TABLET;ORAL	019204-003	Dec 28, 1988		DISCN	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Abbvie	CARTROL	carteolol hydrochloride	TABLET;ORAL	019204-002	Dec 28, 1988		DISCN	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Abbvie	CARTROL	carteolol hydrochloride	TABLET;ORAL	019204-001	Dec 28, 1988		DISCN	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for carteolol hydrochloride

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Novartis	OCUPRESS	carteolol hydrochloride	SOLUTION/DROPS;OPHTHALMIC	019972-001	May 23, 1990	⤷ Subscribe	⤷ Subscribe
Abbvie	CARTROL	carteolol hydrochloride	TABLET;ORAL	019204-002	Dec 28, 1988	⤷ Subscribe	⤷ Subscribe
Abbvie	CARTROL	carteolol hydrochloride	TABLET;ORAL	019204-003	Dec 28, 1988	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.